
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **TPSD1, TPSAB1, TPSB2**: These are tryptase genes, which are serine proteases predominantly found in mast cells. They play a role in the degradation of extracellular matrix components and are involved in inflammatory responses.<br>- **CPA3**: Carboxypeptidase A3 is another enzyme highly expressed in mast cells, involved in the processing of bioactive peptides.<br>- **HDC**: Histidine decarboxylase is responsible for the production of histamine, a key mediator in allergic reactions and inflammation, commonly associated with mast cells.<br>- **HPGDS**: Hematopoietic prostaglandin D synthase is involved in the production of prostaglandin D2, a lipid mediator involved in allergic and inflammatory responses, often linked to mast cells.<br>- **ALOX5, ALOX5AP**: These are involved in leukotriene synthesis, which are inflammatory mediators, again pointing towards mast cell function.<br>- **IL1RL1**: Also known as ST2, this receptor is involved in the immune response and is expressed on mast cells.<br>- **KIT**: A receptor tyrosine kinase that is crucial for mast cell development, survival, and function.<br><br>### Step 2: List the Key Cell Type Markers<br>- **MS4A2**: Also known as FcŒµRIŒ≤, this is a high-affinity IgE receptor subunit, predominantly expressed on mast cells and basophils.<br>- **GATA2**: A transcription factor important for the development and function of mast cells.<br>- **RGS13**: Regulator of G-protein signaling 13, expressed in mast cells and involved in modulating their activation.<br>- **FCER1G**: The gamma chain of the high-affinity IgE receptor, crucial for mast cell activation.<br>- **CD37, CD52**: Surface markers that can be expressed on various immune cells, including mast cells.<br><br>### Step 3: Cross-reference Known Databases<br>Cross-referencing with scRNA-seq databases such as the Human Cell Atlas and literature on breast cancer tissue, the expression of these markers is highly indicative of mast cells. Mast cells are known to infiltrate breast cancer tissues and can influence tumor progression and immune response.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of the markers listed, the most probable general cell type is **Mast Cells**. The presence of tryptases, carboxypeptidase A3, histidine decarboxylase, and the high-affinity IgE receptor subunits strongly supports this annotation.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Connective Tissue Mast Cells**: Typically found in tissues and characterized by the expression of tryptases and carboxypeptidases.<br>2. **Mucosal Mast Cells**: Found in mucosal tissues, but less likely given the context of breast cancer tissue.<br>3. **Tumor-Associated Mast Cells**: A subtype of mast cells that infiltrate tumor tissues and may have distinct functional roles in the tumor microenvironment.<br><br>The most likely subtype, given the context of breast cancer tissue, is **Tumor-Associated Mast Cells**. These cells are known to be present in the tumor microenvironment and can influence tumor progression and immune modulation.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of mast cells. The expression of key markers such as tryptases, carboxypeptidase A3, histidine decarboxylase, and high-affinity IgE receptor subunits strongly supports this conclusion. Among the subtypes, tumor-associated mast cells are the most probable, given their known presence and role in the tumor microenvironment of breast cancer.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation of the cell cluster as "Mast Cells" is consistent with the provided marker list and the context of breast cancer tissue. The key functional markers and cell type markers identified in the annotation are present in the provided marker list, and they are well-known markers for mast cells. The analysis correctly identifies the presence of mast cells, which are known to infiltrate breast cancer tissues and influence tumor progression and immune response.<br><br>The annotation also considers the possibility of subtypes, with "Tumor-Associated Mast Cells" being the most probable given the context. This is a reasonable conclusion based on the expression of the markers and the known role of mast cells in the tumor microenvironment.<br><br>Overall, the annotation is well-supported by the marker list and the context provided, and there is no strong evidence of mixed cell types that would warrant further investigation.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Mast Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Connective Tissue Mast Cells</li><li>Mucosal Mast Cells</li><li>Tumor-Associated Mast Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">95</div>
                        <div class="scoring-content">
                            The annotation results provided are scientifically accurate and well-reasoned. The identification of the cell type as "Mast Cells" is strongly supported by the presence of key markers such as TPSD1, TPSAB1, TPSB2, CPA3, and HDC, which are well-known to be associated with mast cells. The analysis effectively balances the use of different markers, considering both functional markers and cell type-specific markers, such as MS4A2 and GATA2, which further corroborate the identification of mast cells.<br><br>The annotation process demonstrates a comprehensive understanding of the cell population by considering the context of breast cancer tissue. The identification of "Tumor-Associated Mast Cells" as the most probable subtype is a logical conclusion, given the known role of mast cells in the tumor microenvironment and their influence on tumor progression and immune response.<br><br>The analysis does not appear to over-focus on any single marker but rather integrates multiple lines of evidence to support the annotation. The consideration of subtypes, such as connective tissue and mucosal mast cells, adds depth to the analysis, although the context makes tumor-associated mast cells the most relevant subtype.<br><br>One potential area for improvement could be a more explicit consideration of the rank of the markers, as the order of appearance might suggest their relative importance. However, the overall annotation is robust and captures the general picture of the cell populations present in the dataset.<br><br>There are no obvious misclassifications or oversights in the annotation, and the validation step confirms the accuracy of the results. The annotation provides a comprehensive view of the cell types present, making it a reliable and well-supported analysis.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    